Skip to content

Metagenomic analysis of distal gut microbiota of the obesity during Intermittent fasting

Metagenomic analysis of distal gut microbiota of the obesity during Intermittent fasting

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016104
Enrollment
Unknown
Registered
2018-05-11
Start date
2018-07-10
Completion date
Unknown
Last updated
2018-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

intervention:Intermittent Fasting

Sponsors

Nanchang Center for Disease Control and Prevention
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 25 to 65 years male and female; 2. body mass index (BMI)=24 kg/m2; 3. light physical activity (i.e. < 3 h/week of light intensity exercise at 2.5 to 4.0 metabolic equivalents (METs) for 3 months prior to the study), weight stable for 3 months prior to the start of this study (i.e. less than 4 kg weight loss or weight gain in recent three months); 4. subjects are required to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. women who are either in pre-menopause or 2 years post menopause; 2. Patients with diabetes (FPG = 7.0mmol/L and / or OGTT 2h PG = 11.1mmol/L); 3. attended in another study or take weight-loss drugs at the same time or 3 months prior to the beginning of the study; 4. the obvious renal insufficiency (creatinine=1.5 mg/dl or > 133umol/L); 5. the obvious abnormal liver function (ALT more than 2 times of the normal upper limit); 6. ever suffered from history of stroke or myocardial infarction; be done or are preparing to do coronary angioplasty or coronary artery bypass grafting; 7. other serious diseases such as malignant tumor; 8. be preparing for pregnancy; other situations that researchers believe that is not suitable for the selected object.

Design outcomes

Primary

MeasureTime frame
Body Mass Index;Waist Circumference;Total Cholesterol;the relative abundance or composition of microorganisms in the gastrointestinal;

Countries

China

Contacts

Public ContactFan Yibing

Nanchang Center for Disease Control and Prevention

fan_yibing@163.com+86 18079167858

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026